Literature DB >> 1949077

Reversal of murine colchicine toxicity by colchicine-specific Fab fragments.

M Urtizberea1, A Sabouraud, N Cano, M Grandgeorge, J M Rouzioux, J M Scherrmann.   

Abstract

High-affinity Fab fragments (2 x 10(10) M-1) specific to colchicine were produced to evaluate their potency in reversing murine colchicine intoxication. Intraperitoneal injection of a 4.46 mg/kg colchicine dose was lethal for 100% of mice. 1.5 h after colchicine administration, a group of 10 mice was treated with colchicine-specific Fab fragments at a half-stoichiometrical dose compared to the colchicine dose by intravenous and intraperitoneal routes. 70% of the Fab-infused mice survived (P less than 0.01). This high efficiency of colchicine-specific Fab fragments in reversing acute murine colchicine toxicity suggests that Fab fragments would be an efficient antidote for the treatment of human colchicine poisoning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949077     DOI: 10.1016/0378-4274(91)90173-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

Review 2.  Fab antibody fragments: some applications in clinical toxicology.

Authors:  Robert J Flanagan; Alison L Jones
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity.

Authors:  Frédéric J Baud; Bruno Megarbane; Nicolas Deye; Pascal Leprince
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.

Authors:  Michael Eddleston; Nicolas Fabresse; Adrian Thompson; Ibrahim Al Abdulla; Rachael Gregson; Tim King; Alain Astier; Frederic J Baud; R Eddie Clutton; Jean-Claude Alvarez
Journal:  Clin Toxicol (Phila)       Date:  2018-01-15       Impact factor: 4.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.